Macrogenics INC (MGNX) — 10-Q Filings
All 10-Q filings from Macrogenics INC. Browse 5 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (5)
-
Macrogenics' Q3 Profit Plunges Amid Revenue Decline, Cash Burn Accelerates
— Nov 12, 2025 Risk: high
MACROGENICS INC reported a net income of $16.822 million for the three months ended September 30, 2025, a significant decrease from $56.309 million in the same -
MacroGenics Q1 2025 Update: Revenue Streams Detailed
— May 13, 2025 Risk: medium
MacroGenics Inc. reported its first quarter 2025 results for the period ending March 31, 2025. The company's financial filings indicate revenue from collaborati -
MacroGenics Q3 Revenue Surges to $36.6M
— Nov 5, 2024 Risk: medium
MacroGenics Inc. reported its third-quarter 2024 results, with total revenue for the three months ended September 30, 2024, reaching $36.6 million. This represe -
MacroGenics Q2 Revenue Declines to $35.7M
— Aug 6, 2024 Risk: medium
MacroGenics Inc. reported its Q2 2024 results, with total revenue for the three months ended June 30, 2024, reaching $35.7 million, a decrease from $42.5 millio -
Macrogenics Inc. Files 10-Q for Period Ending March 31, 2024
— May 9, 2024 Risk: medium
MACROGENICS INC (MGNX) filed a Quarterly Report (10-Q) with the SEC on May 9, 2024. Macrogenics Inc. reported financial results for the first quarter ended Marc
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX